• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    PetMed Express, Inc. (PETS)

    -NasdaqGS
    14.33 Up 0.10(0.70%) Dec 26, 4:00PM EST
    Add to Portfolio
    ProfileGet Profile for:
    PetMed Express, Inc.
    1441 SW 29th Avenue
    Pompano Beach, FL 33069
    United States - Map
    Phone: 954-979-5995
    Website: http://www.1800petmeds.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Delivery
    Full Time Employees:190

    Business Summary 

    PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats. Its non-prescription medications and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The company’s prescription medications comprise heartworm preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes. In addition, it sells food, beds, crates, stairs, strollers, and other pet supplies through its Website. The company offers its products under the Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution, and Rimadyl brands. It markets its products through television, online, and direct mail/print advertising campaigns, as well as through telephone contact center. The company primarily serves retail customers. PetMed Express, Inc. was founded in 1996 and is headquartered in Pompano Beach, Florida.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on PetMed Express, Inc.

    Corporate Governance 
    PetMed Express, Inc.’s ISS Governance QuickScore as of Dec 1, 2014 is 3. The pillar scores are Audit: 2; Board: 6; Shareholder Rights: 3; Compensation: 5.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Menderes Akdag , 53
    Chief Exec. Officer, Pres, Director and Member of Investment Committee
    736.00K0.00
    Mr. Bruce S. Rosenbloom , 45
    Chief Financial Officer, Principal Accounting Officer and Treasurer
    353.00K0.00
    Ms. Alison Berges ,
    Corp. Sec. and Gen. Counsel
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders